药物信息为Levothyroxine Sodium (Mylan Pharmaceuticals Inc.):
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- ADVERSE REACTIONS
- OVERDOSAGE
- HOW SUPPLIED
- 外部链接相关的Levothyroxine Sodium (Mylan Pharmaceuticals Inc.)
PRINCIPAL DISPLAY PANEL - 200 mcg (0.2 mg)
NDC 0378-1819-01
LEVOTHYROXINESODIUMTABLETS, USP200 mcg(0.2 mg)
100 TABLETS (Rx only)
Each tablet contains:Levothyroxinesodium, USP . . . . . . 200 mcg
Dispense in a tight, light-resistantcontainer as defined in the USPusing a child-resistant closure.
Keep container tightly closed.
Keep this and all medicationout of the reach of children.
Store at 20° to 25°C (68° to 77°F).[See USP for Controlled RoomTemperature.]
Protect from light and moisture.
Usual Dosage: See accompanyingprescribing information.
U.S. Patent Nos. 6,645,526; 6,936,274;7,052,717; 7,195,779
Mylan Pharmaceuticals Inc.Morgantown, WV 26505
RM1819A4

- Drug Information Provided by National Library of Medicine (NLM).
